歴代受賞者一覧
最終更新日：2024年9月6日
|
2024 |
Innovative and/or disruptive research Integrative understanding of super-enhancers involved in cell identity control and cancer pathogenesis Hiroshi Suzuki(Professor, Division of Molecular Oncology,Center for Neurological Diseases and CancerNagoya University Graduate School of Medicine) |
| Translational Research Elucidation of driver mutations and therapeutic targets in cancer and normal tissues Kenichi Yoshida(Chief, Division of Cancer Evolution, National Cancer Center Research Institute) |
|
|
2023 |
Innovative and/or disruptive research Unraveling the Mechanisms of Aberrant Post-Transcriptional Regulation in Cancer: Implications for Therapeutic Strategies Daichi Inoue (Professor, Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe) |
| Translational Research Elucidation of novel mutations and mutational landscape in malignant brain tumors Hiromichi Suzuki (Chief, Division of Brain Tumor Translational Research, National Cancer Center Research Institute) |
|
| 2022 | Innovative and/or disruptive research Understanding and Targeting Aberrant RNA Splicing in Leukemias Akihide Yoshimi (Section Head, Cancer RNA Research Unit, National Cancer Center Research Institute) |
| Translational Research Translational research targeting intractable lymphomas Mamiko Sakata-Yanagimoto (Professor, Department of Hematology, University of Tsukuba) |
|
| 2021 | Innovative and/or disruptive research Genomic Characterization of Diffuse-type Gastric Carcinoma Life Cycle Shumpei Ishikawa (Professor, Department of Preventive Medicine, Graduate Shool of Medicine, The University of Tokyo) |
| Translational Research Development of targeted therapies against tumors with aberrant MAPK singnaling Hiromichi Ebi (Division Head, Division of Molecular Therapeutics, Aichi Cancer Center Research Institute) |
|
| 2020 | Innovative and/or disruptive research Development of synthetic lethal therapy for chromatin regulator deficient cancers Hideaki Ogiwara (Chief, Division of Cancer Therapeutics, National Cancer Center Research Institute) |
| Translational Research Genetic dissection of molecular pathogenesis in human cancer Keisuke Kataoka (Chief, Division of Molecular Oncology, National Cancer Center Research Institute) |
|
| 2019 | Translational research Identification of the resistance mechanisms to molecular targeted therapies and immune checkpoint inhibitor in lung cancer Ryohei Katayama (Chief, Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research) |
| Innovative and/or disruptive research Cancer clonal evolution and involvement ot the microbiota in cancer development Shinichi Yachida (Professor, Department of Cancer Genome Informatic, Graduate School of Medicine, Osaka University) |
|
| 2018 | Translational Research Identifying novel targets for leukemia therapy using the CRISPR/Cas9 gene-editing tool Takahiro Maeda (Center for Celluar and Molecular Medicine/ Kyushu University Hospital) |
| Other research area Mechanisms of cell-cell competition and cooperation in tumorigenesis Tatsushi Igaki (Laboratory of Genetics/ Graduate School of Biostudies Kyoto University) |
|
| 2017 | Basic Dissecting cancer epigenetics with reprogramming technology Yasuhiro Yamada (Laboratory of Stem Cell Oncology, Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University) |
| Applied Immune suppressive mechanisms as a target of effective cancer immunotherapy Hiroyoshi Nishikawa (Division of Cancer Immunology, Research Institute/EPOC, National Cancer Center Department of Immunology, Nagoya University Graduate School of Medicine) |
|
| 2016 | Basic Cancer Genomics for Molecular Diagnosis and Treatment: Genome Sequencing and Genome-wide Association Study Hidewaki Nakagawa (RIKEN Center for Integrated Medical Sciences, Laboratory for Genome Sequencing Analysis) |
| Applied Telomere maintenance system as an anticancer therapeutic target Hiroyuki Seimiya (Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research) |
|
| 2015 | Basic Targeting epigenetics as a new paradigm in cancer treatment Yutaka Kondo (Department of Epigenomics, Nagoya City University Graduate School of Medical Sciences) |
| Applied Identification of molecular therapeutic targets for pediatric cancers Junko Takita (Department of Pediatrics, Graduate School of Medicine, The University of Tokyo) |
|
| 2014 | Basic Cellular senescence and cancer : a gut microbial connection Eiji Hara (Division of Cancer Biology, The Cancer Institute, Japanese Foundation for Cancer Research) |
| Applied Identification and clinical translation of novel diagnostic and therapeutic targets in intractable solid cancers by cancer genome/transcriptome sequencing Tatsuhiro Shibata (Division of Cancer Genomics, National Cancer Center Research Institute) |
|
| 2013 | Basic Molecular study of acute myeloid leukemia and its application for therapy Issay Kitabayashi (Division of Hematological Malignancy, National Cancer Center Research Institute) |
| Applied Circumvention of molecular targeted drug-resistance in lung cancer Seiji Yano (Cancer Research Institute Kanazawa University) |
|
| 2012 | Basic The role of inflammatory responses in gastric cancer development Masanobu Oshima (Division of Genetics, Cancer Research Institute Kanazawa University) |
| Applied Surgical Oncology to Develop Novel Targeted Therapies for Advanced Digestive Cancer Shinji Tanaka (Tokyo Medical and Dental University, Department of Hepato-Biliary-Pancreatic Surgery) |
|
| 2011 | Basic Identification and characterization of p53 target genes Hirofumi Arakawa (Division of Cancer Biology, National Cancer Center Research Institute) |
| Applied Molecular pathogenesis and therapeutic targets of hematologcal malignancies Mineo Kurokawa (Department of Hematology and Oncology Graduate School of Medicine, University of Tokyo) |
|
| 2010 | Basic Identification of molecular targets in cancers through comprehensive cancer genome analysis Seishi Ogawa (Cancer Genomics Project, Graduate School of Medicine University of Tokyo) |
| Applied Analysis of NF-kB/IKK signaling pathways in liver carcinogenesis Shin Maeda (Department of Gastroenterology, Yokohama City University) |
|
| 2009 | Basic Establishment of a novel concept "epigenetic field for cancerization", its mechanistic clarification, and clinical application Toshikazu Ushijima (Carcinogenesis Division National Cancer Center Research Institute) |
| 2008 | Basic Stress Signaling and Cancer Hidenori Ichijo (Laboratory of Cell Signaling Graduate School of Pharmaceutical Sciences The University of Tokyo) |
| Applied Discovery of a novel fusion-type oncogene EML4-ALK in lung cancer Hiroyuki Mano(Division of Functional Genomics Jichi Medical University) |
|
| 2007 | Basic Ubiquitin ligases involved in cell-cycle control and cancer Keiichi Nakayama (Department of Molecular and Cellular Biology Medical Institute of Bioregulation Kyushu University) |
| Applied DNA methylation as a new target for therapy in cancer Minoru Toyota (First Department of Internal Medicine Sapporo Medical University) |
|
| 2006 | Basic The role of Helicobacter pylori CagA in gastric carcinogenesis Masanori Hatakeyama (Division of Molecular Oncology Institute for Genetic Medicine Hokkaido University) |
| Clinical Exploring cancer-associated genes by molecular cytogenetic approach Johji Inazawa(Department of Molecular Cytogenetics, Medical research institute Tokyo Medical & Dental University) |
|
| 2005 | Basic Molecular of Chromosomal Evolution in Cancer Cells Fuyuki Ishikawa (Laboratory of Cell Cycle Regulation Dept. of Gene Mechanisms,Graduate School of Biostudies Kyoto University) |
| Clinical Molecular pathogenesis of? lung cancer and its clinical application Tetsuya Mitsudomi (Department of Thoroacic Surgery Aichi Cancer Center Hospital) |
